Showing results (211-220 of 426) with videos related to
Sort By:
Pageof 43
Drugs|June 12, 2001
Renoprotective therapy in patients with nondiabetic nephropathiesR Pisoni, P Ruggenenti, G RemuzziExpert Opinion on Investigational Drugs|May 1, 1997
Recent developments in the management of membranous nephropathyA Schieppati, A Perna, G RemuzziRenal Physiology and Biochemistry|January 1, 1993
Interleukin-1 and glomerular mesangial cellsC Zoja, A Rambaldi, G RemuzziKidney International. Supplement|April 29, 1998
Nitric oxide/endothelin balance after nephron reductionS Aiello, G Remuzzi, M NorisKidney International|September 5, 2001
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpuraP Ruggenenti, M Noris, G RemuzziAnnali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1993
[The role of endothelin in the progression of the renal disease in an experimental model of chronic kidney failure]S Orisio, C Zoja, G RemuzziCurrent Opinion in Nephrology and Hypertension|March 1, 1994
Treatment of idiopathic membranous glomerulopathyG Remuzzi, A Schieppati, S GarattiniNephron|January 1, 1987
What is the basis for the use of steroids in the treatment of idiopathic membranous nephropathy?S Garattini, T Bertani, G RemuzziLancet (London, England)|November 22, 2001
Modulating the profit motive to meet needs of the less-developed worldA Schieppati, G Remuzzi, S GarattiniJournal of Nephrology|January 19, 2002
The role of the endothelium in hemolytic uremic syndromeC Zoja, M Morigi, G RemuzziPageof 43